Financial Statements — BLLN
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 |
|---|
| Cash & Equivalents | 548.63 | 537.45 | 195.15 |
| Accounts Receivable | 74.89 | 61.31 | 34.65 |
| Inventory | 21.14 | 19.22 | 17.39 |
| Total Current Assets | 651.38 | 624.14 | 251.72 |
| Property, Plant & Equipment | 24.93 | 22.28 | 18.67 |
| Total Non-current Assets* | 78.32 | 76.59 | 75.81 |
| Total Assets | 729.70 | 700.73 | 327.52 |
| Accounts Payable | 12.21 | 8.70 | 7.81 |
| Total Current Liabilities | 55.73 | 57.16 | 40.78 |
| Long-term Debt | 91.03 | 90.01 | 54.99 |
| Total Non-current Liabilities* | 137.17 | 137.95 | 106.84 |
| Total Liabilities | 192.89 | 195.11 | 147.63 |
| Retained Earnings | (248.72) | (256.78) | (280.72) |
| Total Stockholder Equity | 536.81 | 505.62 | (239.51) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 |
|---|
| Total Revenue | 109.45 | 108.39 | 96.05 | 83.52 |
| Cost of Revenue | 32.34 | 29.29 | 27.45 | 25.11 |
| Gross Profit | 77.11 | 79.10 | 68.60 | 58.42 |
| Research & Development | 17.32 | 14.69 | 14.25 | 12.95 |
| Selling, General & Admin | 54.29 | 46.57 | 44.02 | 35.83 |
| Total Operating Expenses | 71.60 | 61.26 | 58.27 | 48.78 |
| Operating Income | 5.50 | 17.83 | 10.33 | 9.63 |
| Pretax Income | 7.52 | 18.51 | 6.30 | 5.58 |
| Tax Provision | (0.54) | 0.54 | 0.32 | (0.13) |
| Net Income | 8.05 | 17.97 | 5.98 | 5.71 |
| Basic EPS | 0.17 | 0.39 | 0.14 | 0.14 |
| Diluted EPS | 0.15 | 0.34 | 0.11 | 0.10 |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 |
|---|
| Operating Cash Flow | 9.14 | 15.43 | 10.79 | 13.80 |
| Capital Expenditures | 4.05 | 4.47 | 1.54 | 7.34 |
| Free Cash Flow* | 5.09 | 10.96 | 9.26 | 6.46 |
| Investing Cash Flow | (4.05) | (4.47) | (1.58) | (7.34) |
| Financing Cash Flow | 6.09 | 30.52 | 291.61 | (2.78) |
* Derived from reported values
